vorinostat has been researched along with Bleb in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futakuchi, A | 1 |
| Inoue, T | 1 |
| Fujimoto, T | 1 |
| Kuroda, U | 1 |
| Inoue-Mochita, M | 1 |
| Takahashi, E | 1 |
| Ohira, S | 1 |
| Tanihara, H | 1 |
1 other study available for vorinostat and Bleb
| Article | Year |
|---|---|
Molecular Mechanisms Underlying the Filtration Bleb-Maintaining Effects of Suberoylanilide Hydroxamic Acid (SAHA).
Topics: Angiogenesis Inhibitors; Blister; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen Type | 2017 |